These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7871391)

  • 41. Mouse lymphoblasts lose their immunogenicity and susceptibility to specific cytotoxic T lymphocyte lysis during maintenance in culture.
    Leshem B; Brass D
    Immunology; 1998 Nov; 95(3):409-18. PubMed ID: 9824505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
    Marsili MA; Walker MC; Phillips-Quagliata JM
    Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of an autoimmune response against syngeneic lymphoma cells by immunogenic 64-kDa protein isolated from normal blast cells of BALB/c mice.
    Stock R; Naor D
    Cancer Immunol Immunother; 1995 Jan; 40(1):48-56. PubMed ID: 7828167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific anti-tumor responses by cultured immune spleen cells. II. Culture supernatants induce specific anti-tumor cytotoxicity by non-immune lymphoid cells in vitro.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Aug; 16(2):292-300. PubMed ID: 1150355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell surface antigen expression on chemically induced murine leukaemias.
    Birch JM; Moore M; Craig AW
    Br J Cancer; 1975 Jun; 31(6):630-40. PubMed ID: 1174442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beneficial activity of Enterococcus faecalis CECT7121 in the anti-lymphoma protective response.
    Castro MS; Molina MA; Di Sciullo P; Azpiroz MB; Leocata Nieto F; Sterín-Speziale NB; Mongini C; Manghi MA
    J Appl Microbiol; 2010 Oct; 109(4):1234-43. PubMed ID: 20477887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific anti-tumor responses of cultured immune spleen cells III. Further characterization of cells which synthesize factors with blocking and antiserum-dependent cellular cytotoxic (ADC) activities.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Oct; 16(4):539-49. PubMed ID: 1080750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer.
    Ichiki Y; Takenoyama M; Mizukami M; So T; Sugaya M; Yasuda M; So T; Hanagiri T; Sugio K; Yasumoto K
    J Immunol; 2004 Apr; 172(8):4844-50. PubMed ID: 15067062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beta 2-integrin dependent aggregate formation between LB T cell lymphoma and spleen cells: assessment of correlation with spleen invasiveness.
    Zahalka MA; Naor D
    Int Immunol; 1994 Jun; 6(6):917-24. PubMed ID: 7522049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
    Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
    J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells.
    Apasov SG; Sitkovsky MV
    J Immunol; 1994 Mar; 152(5):2087-97. PubMed ID: 8133027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
    Parmiani G; Invernizzi G
    Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
    Nagarkatti M; Kaplan AM
    J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of anti-tumor immunity derived from the inoculation of myeloma cells secreting the fusion protein RM4/IFN-tau.
    Qi Y; Moyana T; Chen Y; Xiang J
    Hum Antibodies Hybridomas; 1996; 7(1):21-6. PubMed ID: 8886833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.
    Holladay FP; Lopez G; De M; Morantz RA; Wood GW
    Neurosurgery; 1992 Apr; 30(4):499-504; discussion 504-5. PubMed ID: 1584347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
    Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The syngeneic T-T lymphocyte reaction (STTLR). II. Induction of primary T anti-T cell cytotoxic responses in vitro in T cell cultures stimulated with syngeneic self-reactive T cells.
    Suzuki H; Quintáns J
    J Mol Cell Immunol; 1986; 2(6):345-57. PubMed ID: 3509919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis.
    Van Pel A; Boon T
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4718-22. PubMed ID: 6981814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.